Additional blood sample
Additional blood sample is a biological therapy with 11 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
1
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia
Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)
Study of Circulating Levels of Glicentin
Study of the Anti-tumoral Immune Response
Clinical Trials (11)
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe Thrombocytopenia
Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)
Study of Circulating Levels of Glicentin
Study of the Anti-tumoral Immune Response
Monoclonal Antibodies Elimination in Breast Cancer Patient
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology
Immune Response for Patients With Metastatic Breast Cancer Treated by Everolimus
Research for Specific Proteins of Interest for the Serological Diagnosis of Bird Fancier's Lung
Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients
Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill
All 11 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 11